National Cancer Institute; Notice of Meeting, 36564-36565 [2012-14926]

Download as PDF 36564 Federal Register / Vol. 77, No. 118 / Tuesday, June 19, 2012 / Notices Type of meeting: Open Meeting. Date: June 28, 2012. Time: 1:00 p.m. to 2:30 p.m. *Eastern Time*—Approximate end time. Agenda: To discuss the proposed list of pain research topics that will be used for the portfolio analysis of Federally-funded pain research. Place: No in-person meeting; conference call only. Conference Call: Dial: 800–369–2109, Access Code: 5033271. Cost: The conference call is free and open to the public. Contact Person: Dr. Paul Scott, Director, Office of Science Policy and Planning, National Institute of Neurological Disorders and Stroke, NIH, 31 Center Drive, Room 8A03, Bethesda, MD 20892, (301) 496–9271, Email: IPRCC PublicInquries@mail.nih.gov. Please Note: The conference call will be accessible to the public through a call-in number and access code. Members of the public who participate using the conference call phone number will be able to listen to the meeting but will not be heard. If you experience any technical problems with the conference call, please call Customer Service at 866–900–1011. Individuals who participate by using this electronic service and who need special assistance or other reasonable accommodations should submit a request to the Contact Person listed on this notice at least 7 days prior to the meeting. This meeting is being published less than 15 days prior to the meeting. This timing allows the IPRCC to get feedback from the IPRCC Working Group, who meets the previous week, while still providing time for the recommendations from the teleconference to be implemented before the October 22, 2012, meeting. Information about the IPRCC is available on the Web site: www.iprcc.nih.gov. Dated: June 11, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy . [FR Doc. 2012–14932 Filed 6–18–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health srobinson on DSK4SPTVN1PROD with NOTICES National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial VerDate Mar<15>2010 16:39 Jun 18, 2012 Jkt 226001 property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Clinical Trial Planning Grants in Type 1 Diabetes. Date: July 12, 2012. Time: 4:00 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Carol J. Goter-Robinson, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 748, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7791, goterrobinsonc@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK IBD Genetics Consortium Research Centers U01 Application Review. Date: July 19, 2012. Time: 9:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Xiaodu Guo, MD, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 761, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–4719, guox@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NURSA Hub. Date: August 2, 2012. Time: 1:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Barbara A Woynarowska, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 754, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 402–7172, woynarowskab@niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: June 12, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–14929 Filed 6–18–12; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Minority Health and Health Disparities; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Minority Health and Health Disparities Special Emphasis Panel; NIMHD Support for Conference and Scientific meetings (R13) 2012–10. Date: July 20, 2012. Time: 12:30 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6707 Democracy Blvd., Rm. 851, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Robert Nettey, M.D., Chief, Scientific Review Officer, National Institutes of Health, National Institute on Minority Health and Health Disparities, 6707 Democracy Blvd., Suite 800, Bethesda, MD 20892, (301) 496–3996, netteyr@mail.nih.gov. Dated: June 12, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–14928 Filed 6–18–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the President’s Cancer Panel. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should E:\FR\FM\19JNN1.SGM 19JNN1 Federal Register / Vol. 77, No. 118 / Tuesday, June 19, 2012 / Notices notify the Contact Person listed below in advance of the meeting. would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: President’s Cancer Panel. Date: July 24, 2012. Time: 8:30 a.m. to 4:00 p.m. Agenda: HPV Vaccination as a Model Cancer Prevention Method: State of the, Science and Evidence. Place: Hilton San Francisco Financial District, 750 Kearny Street, San Francisco, CA 94108. Contact Person: Abby B. Sandler, Ph.D., Executive Secretary, Chief, Institute Review Office, Office of the Director, 6116 Executive Blvd., Suite 220, MSC 8349, National Cancer Institute, NIH, Bethesda, MD 20892–8349, (301) 451–9399, sandlera@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/pcp/index.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; NHLBI Conference Grant Review. Date: July 10–11, 2012. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Michael P Reilly, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7200, Bethesda, MD 20892, 301–496–9659, reillymp@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: June 12, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–14926 Filed 6–18–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health srobinson on DSK4SPTVN1PROD with NOTICES National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which VerDate Mar<15>2010 16:39 Jun 18, 2012 Jkt 226001 Dated: June 12, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–14925 Filed 6–18–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of an Interagency Autism Coordinating Committee (IACC) meeting. The purpose of the IACC meeting is for the Secretary of Health and Human Services to welcome new members of the committee and thank previous members for their service. The meeting will include presentations from stakeholders on autism research and policy issues, as well as discussion around newly released IACC documents and plans for future committee activities. The meeting will be open to the public and accessible by live webcast and conference call. Name of Committee: Interagency Autism Coordinating Committee (IACC). Type of meeting: Open Meeting. Date: July 10, 2012. Time: 9:00 a.m. to 5:00 p.m. *Eastern Time*—Approximate end time. Agenda: The Secretary of HHS will welcome new members of the committee and thank previous members for their service. The meeting will include presentations on autism research and policy issues, and the PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 36565 committee will discuss plans for future activities. Place: L’Enfant Plaza Hotel, 408 L’Enfant Plaza, SW., Washington, DC 20024. Conference Call: Dial: 888–455–5419, Access code: 9404105. Cost: The meeting is free and open to the public. Webcast Live: https://videocast.nih.gov/. Registration: https:// www.acclaroresearch.com/oarc/7-10-12/. Pre-registration is recommended to expedite check-in. Seating in the meeting room is limited to room capacity and on a first come, first served basis. Deadlines: Notification of intent to present oral comments: Tuesday, July 3, 2012 by 5:00 p.m. ET Submission of written/electronic statement for oral comments: Thursday, July 5, 2012 by 5:00 p.m. ET Submission of written comments: Thursday, July 5, 2012 by 5:00 p.m. ET. Access: (L’Enfant Plaza Metro) Orange, Blue, Yellow, and Green Lines. Contact Person: Ms. Lina Perez, Office of Autism Research Coordination, National Institute of Mental Health, NIH, 6001 Executive Boulevard, NSC, Room 6182A, Rockville, MD 20852, Phone: (301) 443–6040, Email: IACCPublicInquiries@mail.nih.gov. Please Note: Any member of the public interested in presenting oral comments to the Committee must notify the Contact Person listed on this notice by 5:00 p.m. ET on Tuesday, July 3, 2012, with their request to present oral comments at the meeting. Interested individuals and representatives of organizations must submit a written/ electronic copy of the oral statement/ comments including a brief description of the organization represented by 5:00 p.m. ET on Thursday, July 5, 2012. Statements submitted will become a part of the public record. Only one representative of an organization will be allowed to present oral comments on behalf of that organization, and presentations will be limited to three to five minutes per speaker, depending on number of speakers to be accommodated within the allotted time. Speakers will be assigned a time to speak in the order of the date and time when their request to speak is received, along with the required submission of the written/electronic statement by the specified deadline. If special accommodations are needed, please email the Contact Person listed above. In addition, any interested person may submit written comments to the IACC prior to the meeting by sending the comments to the Contact Person listed on this notice by 5:00 p.m. ET, Thursday, July 5, 2012. The comments should include the name and, when applicable, the business or professional affiliation of the interested person. All written comments received by the deadlines for both oral and written public comments will be provided to the IACC for their consideration and will become part of the public record. The meeting will be open to the public through a conference call phone number and webcast live on the Internet. Members of the public who participate using the conference call phone number will be able to listen to the meeting but will not be heard. If you experience any technical E:\FR\FM\19JNN1.SGM 19JNN1

Agencies

[Federal Register Volume 77, Number 118 (Tuesday, June 19, 2012)]
[Notices]
[Pages 36564-36565]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-14926]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
President's Cancer Panel.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should

[[Page 36565]]

notify the Contact Person listed below in advance of the meeting.

    Name of Committee: President's Cancer Panel.
    Date: July 24, 2012.
    Time: 8:30 a.m. to 4:00 p.m.
    Agenda: HPV Vaccination as a Model Cancer Prevention Method: 
State of the, Science and Evidence.
    Place: Hilton San Francisco Financial District, 750 Kearny 
Street, San Francisco, CA 94108.
    Contact Person: Abby B. Sandler, Ph.D., Executive Secretary, 
Chief, Institute Review Office, Office of the Director, 6116 
Executive Blvd., Suite 220, MSC 8349, National Cancer Institute, 
NIH, Bethesda, MD 20892-8349, (301) 451-9399, sandlera@mail.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://deainfo.nci.nih.gov/advisory/pcp/index.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: June 12, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-14926 Filed 6-18-12; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.